Last reviewed · How we verify
NCT05608902: DOCTOBA
Structural Description of Skin Biopsies With Dynamic Full-field Optical Coherence Tomography on Suspected Basal Cell Carcinoma Lesions, a Pilot Study (DOCTOBA)
trial testing Dynamic full-field optical coherence tomography analysis of skin biopsy or resection in Basal Cell Carcinoma in 22 participants. Completed in 31 March 2023.
26 January 2023
Quick facts
| Lead sponsor | Centre Hospitalier William Morey - Chalon sur Saône |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 22 |
| Start date | 6 September 2022 |
| Primary completion | 26 January 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- Dynamic full-field optical coherence tomography analysis of skin biopsy or resection
Conditions studied
- Basal Cell Carcinoma — all drugs for Basal Cell Carcinoma →
- Tomography, Optical Coherence — all drugs for Tomography, Optical Coherence →
Sponsor
Centre Hospitalier William Morey - Chalon sur Saône
Who can join
18 and older, any sex, with Basal Cell Carcinoma or Tomography, Optical Coherence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Basal cell carcinoma (BCC) are the most frequent skin cancers. Their incidence is constantly increasing. BCC diagnosis is first clinically suspected and then confirmed following histological examination of either a skin biopsy or the excisional specimen. Surgery is the first-line treatment and some procedures (notably Mohs surgery) require extemporaneous histological analysis of the edges to ensure a complete excision. Such on-site histopathological examination can be time consuming and associated with decreased sensitivity. Skin imaging techniques have already been tested to overcome these limitations and seem promising. Although some of them - such as confocal microscopy - are already even used in vivo, there is to date no report of the use of full-field optical coherence tomography for the diagnosis of BCC. The DOCTOBA study intends to describe direct histopathological examination of fresh skin biopsy or excisional specimen with dynamic full-field optical coherence tomography.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05608902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Basal Cell Carcinoma
Currently open trials in the same condition.
- NCT07182240 — Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Ba · NA · recruiting
- NCT07285044 — The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr · Phase 2 · recruiting
- NCT06600165 — Intraoperative Confocal Laser Scanning Microscopy With Use of AI for Optimized Surgical Excision of Basal Cell Carcinoma · recruiting
- NCT06384924 — Raman Spectroscopy and Skin Cancer · recruiting
- NCT06384053 — Skin Cancer and Hyperthermia and Radiotherapy · NA · recruiting
Other Centre Hospitalier William Morey - Chalon sur Saône trials
Trials by the same sponsor.
- NCT06611800 — Personalized Advance Prescriptions in Palliative Care at HOME: Interests and Difficulties of Its Implementation · completed
- NCT06216080 — Dynamic Full-Field Optical Coherence Tomography for Structural and Microbiological Characterization of Central Venous Ca · completed
- NCT05663333 — Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Compar · completed
- NCT05728216 — Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conve · recruiting
- NCT05635136 — Histopathological Analysis of Renal Biopsies With Dynamic Full-field Optical Coherence Tomography, a Comparison to Conve · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05608902 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier William Morey - Chalon sur Saône
- Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05608902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing